N2O for Acute Suicidality and Depression in the ED

Withdrawn before enrolling · Phase 2 · Has a placebo group

Conditions studied: Suicidal Ideation, Major Depressive Disorder, Treatment Resistant Depression

In brief

Investigators are conducting this double-blind, randomized control trial (RCT), to compare inhaled N2O+ treatment as usual (TAU) versus inhaled placebo+TAU; demonstrating the feasibility and tolerability of the intervention in an emergency department (ED) setting on an acutely suicidal population.

Key facts

Study ID
NCT05710887
Run by
University of Chicago
People needed
0
Starts
2026-02-27
Expected to finish
2026-02-27
Last updated by the study team
2026-03-04

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.